Groowe Groowe / Newsroom / EIKN
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

EIKN News

Eikon Therapeutics, Inc. Common Stock

Form 8-K

sec.gov
EIKN MRNA AMGN

Eikon Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Clinical and Corporate Updates

globenewswire.com
EIKN

Eikon Therapeutics Announces Pricing of Upsized Initial Public Offering

globenewswire.com
EIKN